Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Sun Joo Cha, Kiyoung Kim
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2022-01-01
Reeks:	Antioxidants
Onderwerpen:	edaravone oxidative stress antioxidant mitochondria neurodegenerative disease amyotrophic lateral sclerosis
Online toegang:	https://www.mdpi.com/2076-3921/11/2/195

Gelijkaardige items

A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
door: Erdi Şahin
Gepubliceerd in: (2018-03-01)

Edaravone: A new hope for patients with amyotrophic lateral sclerosis
door: Shivangi Garg, et al.
Gepubliceerd in: (2019-01-01)

Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
door: Hideki Houzen, et al.
Gepubliceerd in: (2021-07-01)

Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study
door: Jin-Mo Park, et al.
Gepubliceerd in: (2022-07-01)

Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
door: Chang Liu, et al.
Gepubliceerd in: (2024-10-01)

Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone
door: Hee Jo Han, et al.
Gepubliceerd in: (2022-12-01)

New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments
door: Maria A. Lapshina, et al.
Gepubliceerd in: (2023-11-01)

Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report
door: Kabindra Rai, et al.
Gepubliceerd in: (2023-02-01)

The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
door: Jiantao Zhao, et al.
Gepubliceerd in: (2022-06-01)

Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis
door: Hyun-Jun Choi, et al.
Gepubliceerd in: (2020-09-01)

Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
door: Benjamin Rix Brooks, et al.
Gepubliceerd in: (2022-10-01)

Iranian clinical practice guideline for amyotrophic lateral sclerosis
door: Reza Boostani, et al.
Gepubliceerd in: (2023-06-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
door: Kamila Tuzim, et al.
Gepubliceerd in: (2018-08-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
door: Kamila Tuzim, et al.
Gepubliceerd in: (2018-08-01)

The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing
door: Aki Soejima-Kusunoki, et al.
Gepubliceerd in: (2022-07-01)

Amyotrophic lateral sclerosis with frontotemporal dementia
door: Corina Roman-Filip, et al.
Gepubliceerd in: (2010-09-01)

Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes
door: Eleonora Colombo, et al.
Gepubliceerd in: (2023-10-01)

Advancements and challenges in amyotrophic lateral sclerosis
door: David Bradford, et al.
Gepubliceerd in: (2024-05-01)

Intestinal Microbiota and Sclerosis Lateral Amyotrophic
door: Mariana Dantas de Carvalho Vilar, et al.
Gepubliceerd in: (2022-03-01)

The implications of DNA methylation for amyotrophic lateral sclerosis
door: ADRIANA HELENA DE OLIVEIRA REIS, et al.
Gepubliceerd in: (2023-10-01)

The role of statins in amyotrophic lateral sclerosis: protective or not?
door: Hayder M. Al-kuraishy, et al.
Gepubliceerd in: (2024-06-01)

Evaluation of Sensory Nerve Conduction Abnormalities in Patients with Amyotrophic Lateral Sclerosis
door: Waseem H. Alkhaffaf
Gepubliceerd in: (2021-06-01)

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
door: Frances Theunissen, et al.
Gepubliceerd in: (2021-11-01)

Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704
door: Dong Wook Kang, et al.
Gepubliceerd in: (2021-09-01)

Prevalence of amyotrophic lateral sclerosis in Latium region, Italy
door: Maria Puopolo, et al.
Gepubliceerd in: (2021-12-01)

Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
door: Niccolò Candelise, et al.
Gepubliceerd in: (2022-03-01)

Progress in the study of mitochondrial dysfunction in pathogenesis of amyotrophic lateral sclerosis
door: LIU Liyang, LIU Qing, LIU Yaping, ZHANG Xue
Gepubliceerd in: (2023-02-01)

Amyotrophic lateral sclerosis: pathogenetic mechanisms and new approaches to pharmacotherapy (literature review)
door: T. M. Alekseeva, et al.
Gepubliceerd in: (2019-01-01)

Commentary: Urinary Neopterin, a New Marker of the Neuroinflammatory Status in Amyotrophic Lateral Sclerosis
door: Gisele Espíndola, et al.
Gepubliceerd in: (2021-03-01)

Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients
door: Swapnil Samadhiya, et al.
Gepubliceerd in: (2022-01-01)

Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage
door: Marguerite Jamet, et al.
Gepubliceerd in: (2024-03-01)

Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols
door: Anne Vejux, et al.
Gepubliceerd in: (2018-01-01)

The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
door: Christoph Schweingruber, et al.
Gepubliceerd in: (2022-08-01)

Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis
door: Mengli Wang, et al.
Gepubliceerd in: (2021-06-01)

Depression in amyotrophic lateral sclerosis
door: Joanna Iłżecka
Gepubliceerd in: (2021-10-01)

Amyotrophic lateral sclerosis : advances and perspectives of neuronanomedicine /
door: Machtoub, Lina, author, et al.
Gepubliceerd in: (2016)

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
door: HaEun Cho, et al.
Gepubliceerd in: (2020-12-01)

Staging model for amyotrophic lateral sclerosis in Singapore
door: Yuan Teck Tay, et al.
Gepubliceerd in: (2022-07-01)

Analysis of SOD1 and C9orf72 mutations in patients with amyotrophic lateral sclerosis in Antioquia, Colombia
door: Jimena Jaramillo, et al.
Gepubliceerd in: (2022-12-01)

Pain in Amyotrophic Lateral Sclerosis Is Underrated
door: Soyoung Kwak, et al.
Gepubliceerd in: (2024-12-01)